⚕️
Medikal Tanı ve Test Sektörü Hisseleri
Medikal Tanı ve Test Sektörü altında 222 Hisse Senedi
Medikal Tanı ve Test sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
100
Toplam Hisse
$2.3T
Toplam Piyasa Değeri
Medikal Tanı ve Test Sektörü Hisseleri
Sayfa 1/3 (Toplam: 222)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | $697.04B | $776.44 | 1.87% |
| ABT | Abbott Laboratories | $218.75B | $125.73 | 1.05% |
| TMO | Thermo Fisher Scientific Inc. | $161.42B | $427.62 | 5.60% |
| BSX | Boston Scientific Corporation | $152.62B | $103.16 | 0.60% |
| DHR | Danaher Corporation | $135.91B | $189.91 | 0.98% |
| VRTX | Vertex Pharmaceuticals Incorporated | $120.73B | $470.13 | 2.54% |
| MDT | Medtronic plc | $117.43B | $91.65 | 2.17% |
| ZTS | Zoetis Inc. | $67.31B | $151.19 | 2.59% |
| REGN | Regeneron Pharmaceuticals, Inc. | $59.54B | $560.93 | 2.82% |
| EW | Edwards Lifesciences Corporation | $44.76B | $76.30 | 0.33% |
| IDXX | IDEXX Laboratories, Inc. | $42.78B | $532.00 | 2.14% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $42.41B | $325.28 | 1.49% |
| GEHC | GE HealthCare Technologies Inc. | $35.02B | $76.49 | 3.13% |
| DXCM | DexCom, Inc. | $33.38B | $85.12 | 1.30% |
| LH | Laboratory Corporation of America Holdings | $21.09B | $252.07 | 3.72% |
| DGX | Quest Diagnostics Incorporated | $19.90B | $178.24 | 7.08% |
| NTRA | Natera, Inc. | $19.11B | $139.92 | 0.50% |
| ILMN | Illumina, Inc. | $16.15B | $102.03 | 7.63% |
| HOLX | Hologic, Inc. | $14.57B | $65.37 | 2.64% |
| MEDP | Medpace Holdings, Inc. | $13.73B | $477.73 | 54.67% |
| SOLV | Solventum Corporation | $12.62B | $72.92 | 0.80% |
| EXEL | Exelixis, Inc. | $12.13B | $44.47 | 0.47% |
| DVA | DaVita Inc. | $11.03B | $146.05 | 4.75% |
| TEM | Tempus AI, Inc. | $10.27B | $61.08 | 5.29% |
| EXAS | Exact Sciences Corporation | $9.40B | $49.83 | 3.04% |
| AVTR | Avantor, Inc. | $8.87B | $13.02 | 5.53% |
| HSIC | Henry Schein, Inc. | $8.79B | $72.20 | 4.53% |
| BBIO | BridgeBio Pharma, Inc. | $8.69B | $45.77 | 0.28% |
| BPMC | Blueprint Medicines Corporation | $8.36B | $129.46 | 0.14% |
| TECH | Bio-Techne Corporation | $8.33B | $53.12 | 5.67% |
| BIO | Bio-Rad Laboratories, Inc. | $6.68B | $245.47 | 0.50% |
| IONS | Ionis Pharmaceuticals, Inc. | $6.68B | $41.95 | 0.96% |
| CHE | Chemed Corporation | $6.63B | $452.87 | 0.77% |
| RGEN | Repligen Corporation | $6.41B | $114.12 | 0.59% |
| BRKR | Bruker Corporation | $5.88B | $38.80 | 8.88% |
| GH | Guardant Health, Inc. | $5.73B | $46.25 | 1.34% |
| LNTH | Lantheus Holdings, Inc. | $5.00B | $72.34 | 1.09% |
| RDNT | RadNet, Inc. | $4.39B | $57.14 | 1.38% |
| IRTC | iRhythm Technologies, Inc. | $4.26B | $133.38 | 1.58% |
| ADMA | ADMA Biologics, Inc. | $4.07B | $17.05 | 0.47% |
| RNA | Avidity Biosciences, Inc. | $4.04B | $33.53 | 1.44% |
| SRRK | Scholar Rock Holding Corporation | $3.80B | $39.98 | 2.77% |
| PTCT | PTC Therapeutics, Inc. | $3.68B | $46.39 | 3.07% |
| HAE | Haemonetics Corporation | $3.56B | $74.21 | 0.60% |
| NVST | Envista Holdings Corp | $3.40B | $20.04 | 2.93% |
| SHC | Sotera Health Company | $3.22B | $11.36 | 3.18% |
| AMED | Amedisys, Inc. | $3.22B | $97.97 | 0.27% |
| KYMR | Kymera Therapeutics, Inc. | $3.21B | $45.76 | 1.37% |
| RXRX | Recursion Pharmaceuticals, Inc. | $2.78B | $6.54 | 2.19% |
| CON | Concentra Group Holdings Parent, Inc. | $2.53B | $19.77 | 0.90% |
| APLS | Apellis Pharmaceuticals, Inc. | $2.50B | $19.89 | 3.16% |
| RARE | Ultragenyx Pharmaceutical Inc. | $2.50B | $26.44 | 0.19% |
| IBRX | ImmunityBio, Inc. | $2.39B | $2.71 | 1.12% |
| TWST | Twist Bioscience Corporation | $2.15B | $35.83 | 3.05% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $2.07B | $14.96 | 1.70% |
| DNLI | Denali Therapeutics Inc. | $2.01B | $13.87 | 0.29% |
| CGON | CG Oncology, Inc. Common stock | $1.98B | $26.01 | 3.29% |
| PGNY | Progyny, Inc. | $1.97B | $22.98 | 0.17% |
| BLTE | Belite Bio, Inc | $1.94B | $59.67 | 2.65% |
| IDYA | IDEAYA Biosciences, Inc. | $1.93B | $22.02 | 0.96% |
| FOLD | Amicus Therapeutics, Inc. | $1.92B | $6.22 | 2.81% |
| QDEL | QuidelOrtho Corporation | $1.73B | $25.54 | 0.95% |
| CERT | Certara, Inc. | $1.72B | $10.62 | 4.73% |
| TXG | 10x Genomics, Inc. | $1.62B | $12.99 | 12.56% |
| ADPT | Adaptive Biotechnologies Corporation | $1.60B | $10.53 | 2.13% |
| AZTA | Azenta, Inc. | $1.51B | $32.92 | 5.11% |
| ARDT | Ardent Health Partners, LLC | $1.50B | $10.51 | 4.02% |
| TDOC | Teladoc Health, Inc. | $1.48B | $8.42 | 1.08% |
| DVAX | Dynavax Technologies Corporation | $1.34B | $11.18 | 2.19% |
| GRAL | GRAIL, Inc. | $1.34B | $37.16 | 8.18% |
| NVAX | Novavax, Inc. | $1.17B | $7.22 | 0.70% |
| ASTH | Astrana Health, Inc. | $1.15B | $22.96 | 0.35% |
| PRAX | Praxis Precision Medicines, Inc. | $1.13B | $55.41 | 0.45% |
| MD | Pediatrix Medical Group, Inc. | $1.09B | $12.74 | 0.79% |
| OPK | OPKO Health, Inc. | $1.09B | $1.38 | 1.43% |
| NEOG | Neogen Corporation | $1.09B | $5.02 | 5.02% |
| RCUS | Arcus Biosciences, Inc. | $969.91M | $9.16 | 1.08% |
| IMNM | Immunome, Inc. | $963.23M | $11.07 | 2.31% |
| PROK | ProKidney Corp. | $896.60M | $3.05 | 5.28% |
| KMTS | Kestra Medical Technologies, Ltd. Common Stock | $874.47M | $17.03 | 2.41% |
| NRIX | Nurix Therapeutics, Inc. | $860.06M | $11.25 | 0.00% |
| GERN | Geron Corporation | $815.26M | $1.28 | 4.07% |
| NUVB | Nuvation Bio Inc. | $797.27M | $2.35 | 0.21% |
| DNA | Ginkgo Bioworks Holdings, Inc. | $781.40M | $13.35 | 17.93% |
| CDNA | CareDx, Inc | $724.96M | $13.02 | 2.12% |
| TNGX | Tango Therapeutics, Inc. | $724.07M | $6.68 | 1.33% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $677.65M | $2.53 | 6.30% |
| GYRE | Gyre Therapeutics, Inc. | $653.04M | $7.23 | 1.83% |
| BBNX | Beta Bionics, Inc. | $648.61M | $14.96 | 4.62% |
| BCAX | Bicara Therapeutics Inc. Common Stock | $624.44M | $11.45 | 1.87% |
| ABUS | Arbutus Biopharma Corporation | $603.31M | $3.15 | 0.32% |
| KURA | Kura Oncology, Inc. | $577.45M | $6.67 | 3.09% |
| PSNL | Personalis, Inc. | $567.93M | $6.43 | 3.71% |
| FLGT | Fulgent Genetics, Inc. | $567.16M | $18.63 | 4.96% |
| RGLS | Regulus Therapeutics Inc. | $564.95M | $8.16 | 0.00% |
| CBLL | CeriBell, Inc. | $560.94M | $15.52 | 2.04% |
| KROS | Keros Therapeutics, Inc. | $557.65M | $13.73 | 0.44% |
| NUTX | Nutex Health, Inc. | $555.57M | $100.01 | 10.05% |
| SMLR | Semler Scientific, Inc. | $554.16M | $40.19 | 1.31% |
| AVNS | Avanos Medical, Inc. | $547.07M | $11.83 | 3.86% |